MedPath

24 hours patch test to verify the Primary irritation of a research product

Not Applicable
Completed
Registration Number
CTRI/2014/02/004427
Lead Sponsor
Stempeutics Research Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

Healthy male and female subjects in the ration of 1:1.

Subjects with skin phototype III to V and Subjects willing to keep the patch in position for 24 hours.

Subjects willing to come for follow up visit at specified interval for 9 days.

Subjects ready to follow instructions during the study period.

Subjects with healthy skin on the studied anatomic unit (free of eczema, wounds and inflammatory scars).

Subjects representing varied skin types (representation of all 4 skin types â?? oily, normal, dry and combination).

Exclusion Criteria

Subjects having infection, allergy, bruises or scars on the area to be tested.

Subjects having known hypersensitivity to any component of the tested products.

Subjects having sensitivity to penicillin, based on history or as confirmed by a sensitivity test on forearm.

Athletes and subjects with history of excessive sweating.

Subjects with cutaneous disease that may influence the study result as per investigatorâ??s judgment.

Subjects having chronic illness that may influence the cutaneous state (for example: SLE) as per investigatorâ??s judgment.

Subjects on oral corticosteroid therapy.

Any history of underlying uncontrolled medical illness (including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness) which in the investigatorâ??s opinion will have safety concerns for the subject.

For females: Being pregnant or breastfeeding or having stopped breastfeeding within the last three months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
verification of safety of Investigation product by evaluating the irritation potentialTimepoint: 24hrs 48hrs and 7 days after patch application
Secondary Outcome Measures
NameTimeMethod
DrynessTimepoint: 24hrs 48hrs and 7 days after patch application
© Copyright 2025. All Rights Reserved by MedPath